meta_analysis
2013
High Quality
L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis
DiNicolantonio JJ, Lavie CJ, Fares H
Published in Mayo Clinic Proceedings
Key Findings
L-carnitine after myocardial infarction was associated with reduced all-cause mortality, arrhythmias and angina, but not reinfarction.
Conclusions
Possible secondary-prevention benefit, mostly from older trials.
Limitations
Older trials, high risk of bias.
Supplements Studied
L-Carnitine
Amino Acid
L-carnitine was associated with reduced all-cause mortality after acute myocardial infarction, but no reduction in reinfarction or heart failure.
Related Health Concerns
Study Details
Year:2013
Sample Size:3,629
Quality Score:7/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.